Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
SAMHD1 is active in cycling cells permissive to HIV-1 infection.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
Highlights of the 30th International Conference on Antiviral Research.
Antiviral treatment strategies based on gene silencing and genome editing.
Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.
Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors.
Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors.
The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells.
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.